Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E Cigarettes
Trial details
- Registry ID
- NCT07392125
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E CigarettesNCT07392125 | Achieve Life Sciences | Phase 3 | Not yet recruiting | 2026-11-15Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |